✦ LIBER ✦

Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis

✍ Scribed by G. Cavaletti; P. Perseghin; M. Dassi; R. Cavarretta; M. Frigo; D. Caputo; L. Stanzani; E. Tagliabue; C. Zoia; M. Grimaldi; V. Isella; S. Rota; C. Ferrarese; L. Frattola

Publisher: Springer Milan
Year: 2006
Tongue: English
Weight: 219 KB
Volume: 27
Category: Article
ISSN: 1590-1874
DOI: 10.1007/s10072-006-0561-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of natalizumab

Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational study

✍ F. Sangalli; L. Moiola; S. Bucello; P. Annovazzi; A. Rizzo; M. Radaelli; G. Vite 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 238 KB

A post-marketing study on immunomodulati

A post-marketing study on immunomodulating treatments for relapsing-remitting multiple sclerosis in Lombardia: preliminary results

✍ C. Milanese; E. Beghi; L. Giordano; L. La Mantia; N. Mascoli; P. Confalonieri; a 📂 Article 📅 2005 🏛 Springer Milan 🌐 English ⚖ 61 KB

The effect of natalizumab on cognitive f

The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study

✍ Flavia Mattioli; C. Stampatori; R. Capra 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 164 KB

Safety and efficacy of bortezomib and me

Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up

✍ James R. Berenson; Hank H. Yang; Robert A. Vescio; Youram Nassir; Russell Mapes; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 164 KB